News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Guotai Haitong: CN Public Funds Continue to Increase Holdings in H Shrs in 2Q, Adding Stocks of Innovative Drugs, New Consumption & Div., Reducing Tech Stocks
The public funds in Mainland China continued to increase their holdings in Hong Kong stocks in 2Q25, Guotai Haitong Securities said in a report. By index, mainland public funds mai...
Reset
Send
The window will close in 5 seconds
<Research>Guotai Haitong: CN Public Funds Continue to Increase Holdings in H Shrs in 2Q, Adding Stocks of Innovative Drugs, New Consumption & Div., Reducing Tech Stocks
Close
Recommend
99
Positive
156
Negative
73
 
 

The public funds in Mainland China continued to increase their holdings in Hong Kong stocks in 2Q25, Guotai Haitong Securities said in a report.

By index, mainland public funds mainly increased holdings in small and mid-cap stocks. In 2Q25, the proportion of constituent stocks of the Hang Seng Small and Mid-Cap Index in the total market cap of Hong Kong stocks held by funds increased by 5.6 ppts QoQ, while the proportions of holdings in the HSI and HSTECH sank 4.4 and 8.3 ppts QoQ respectively.

Related NewsUBS Rates WUXI APPTEC as Buy w/ TP HKD104.6; Interim Results in Line
By industry, mainland public funds majorly increased holdings in the pharmaceutical and biological, light manufacturing, non-bank and banking sectors in 2Q25, corresponding to concepts such as innovative drugs, new consumption, and dividends. They reduced holdings in the technology sector of Hong Kong stocks, which had leapfrogged in 1Q25 due to Deepseek's catalyst, corresponding to concepts such as the internet and automobiles.

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.